Skip to main content
Top

Clinical & Experimental Metastasis

Issue 5/2000

Content (11 Articles)

Promotion of colon cancer metastases in rat liver by fish oil diet is not due to reduced stroma formation

Lars Klieverik, Olav Fehres, Patrizia Griffini, Cornelis J.F. Van Noorden, Wilma M. Frederiks

Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model

Natalie C. Lee, Michael Bouvet, Stephanie Nardin, Ping Jiang, Eugene Baranov, Babak Rashidi, Meng Yang, Xiaoen Wang, A.R. Moossa, Robert M. Hoffman

Dual X-ray absorptiometry detects disease- and treatment-related alterations of bone density in prostate cancer patients

Gillian L. Smith, Alan P. Doherty, Linda M. Banks, Jane Dutton, Iain W. Hanham, Timothy J. Christmas, Richard J. Epstein

Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells

Aye Aye Thant, Akihiro Nawa, Fumitaka Kikkawa, Yasukatu Ichigotani, Yangying Zhang, Thet Thet Sein, A.R.M. Ruhul Amin, Michinari Hamaguchi

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression

Mohammad R. Shaker, Guang Yang, Terry L. Timme, Sang H. Park, Dov Kadmon, Chengzhen Ren, Xiaorong Ji, Hon-Man Lee, Inder Sehgal, Mario Anzano, Michael B. Sporn, Timothy C. Thompson

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine